Tapewire

Nasdaq · USD

NUTX

Nutex Health Inc.

Export transactions ↓
Tapewire entity
4803
SEC CIK
0001479681
Parsed reports
166

Last 12 months

Inside the activity.

5 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202640
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 18, 2026 Filed Sep 18, 2026 18:51 UTC SaleCommon Stock 203 $214.25 $43,492.75
Disclosure

SEC source: 0002018971-26-000004 · primary_doc.xml · nonDerivative · entry 1

Saunders Scott J · CIK 0002018971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400

Read SEC document
July 31, 2026 Filed Aug 3, 2026 09:59 UTC Exercise / conversionCommon Stock 603 $0.00 $0.00
Disclosure

SEC source: 0001922252-26-000003 · primary_doc.xml · nonDerivative · entry 1

Reed Michael Lee · CIK 0001922252 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (2)

Disclosed balance after: 670

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common shares on a one-for-one basis.

F2 · ownership.nature: Michael L Reed Trust IRA ("MLRTIRA"), the direct beneficial owner of 67 shares of Common Stock. Michael L Reed, the sole trustee of MLRTIRA, is the indirect beneficial owner of such shares.

Read SEC document
July 31, 2026 Filed Aug 3, 2026 10:07 UTC Exercise / conversionCommon Stock 603 $0.00 $0.00
Disclosure

SEC source: 0001920511-26-000003 · primary_doc.xml · nonDerivative · entry 1

Grenas Cheryl Yvonne · CIK 0001920511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 670

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
July 31, 2026 Filed Aug 3, 2026 14:10 UTC Exercise / conversionCommon Stock 603 $0.00 $0.00
Disclosure

SEC source: 0001303609-26-000004 · primary_doc.xml · nonDerivative · entry 1

Jaumot Frank E · CIK 0001303609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 753

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
July 31, 2026 Filed Aug 3, 2026 14:04 UTC Exercise / conversionCommon Stock 603 $0.00 $0.00
Disclosure

SEC source: 0002018971-26-000003 · primary_doc.xml · nonDerivative · entry 1

Saunders Scott J · CIK 0002018971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 603

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
June 04, 2026 Filed Jun 4, 2026 17:23 UTC OtherCommon Stock 2,519 $0.00 $0.00
Disclosure

SEC source: 0002018803-26-000003 · primary_doc.xml · nonDerivative · entry 1

Spears Kelvin · CIK 0002018803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,656

F1 · price: Represents the issuance in private transaction of 2,519 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of one under construction hospital previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026.

Read SEC document
May 28, 2026 Filed May 29, 2026 17:16 UTC
Vo Thomas T.Director · Chief Executive Officer
OtherCommon Stock 75,747 $0.00 $0.00
Disclosure

SEC source: 0001919945-26-000003 · primary_doc.xml · nonDerivative · entry 1

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Micro Hospital Holdings LLC

Disclosed balance after: 2,103,014

F1 · price: Represents the issuance in private transaction of 62,994 and 12,753 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of two under construction hospitals previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026.

F2 · ownership.nature: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of the securities of the registrant reported herein.

Read SEC document
April 23, 2026 Filed Apr 24, 2026 18:35 UTC GrantRestricted Stock Units (RSUs) · Derivative 823 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001922252-26-000002 · primary_doc.xml · derivative · entry 1

Reed Michael Lee · CIK 0001922252 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,426

Underlying: Common Stock · 823 shares

Expires 2027-04-23

F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F1 · price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

F2 · derivative.expiration_date: On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Read SEC document
April 23, 2026 Filed Apr 24, 2026 18:21 UTC GrantRestricted Stock Units (RSUs) · Derivative 823 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001920511-26-000002 · primary_doc.xml · derivative · entry 1

Grenas Cheryl Yvonne · CIK 0001920511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,426

Underlying: Common Stock · 823 shares

Expires 2027-04-23

F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F1 · shares: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F1 · price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

F2 · derivative.expiration_date: On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Read SEC document
April 23, 2026 Filed Apr 24, 2026 18:27 UTC GrantRestricted Stock Units (RSUs) · Derivative 823 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001303609-26-000003 · primary_doc.xml · derivative · entry 1

Jaumot Frank E · CIK 0001303609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,426

Underlying: Common Stock · 823 shares

Expires 2027-04-23

F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F1 · price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

F2 · derivative.expiration_date: On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Read SEC document
April 23, 2026 Filed Apr 24, 2026 18:32 UTC GrantRestricted Stock Units (RSUs) · Derivative 823 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0002018971-26-000002 · primary_doc.xml · derivative · entry 1

Saunders Scott J · CIK 0002018971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,426

Underlying: Common Stock · 823 shares

Expires 2027-04-23

F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F1 · price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

F2 · derivative.expiration_date: On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Read SEC document
April 09, 2026 Filed Apr 10, 2026 20:18 UTC
Vo Thomas T.Director · Chief Executive Officer
OtherCommon Stock 184,071 $0.00 $0.00
Disclosure

SEC source: 0001919945-26-000002 · primary_doc.xml · nonDerivative · entry 1

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Micro Hospital Holdings LLC

Disclosed balance after: 2,027,267

F1 · price: Represents the issuance in private transaction of 95,076 and 88,995 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of two under construction hospitals previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026.

F2 · ownership.nature: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of the securities of the registrant reported herein.

Read SEC document
March 20, 2026 Filed Mar 23, 2026 17:11 UTC PurchaseCommon Stock 150 $93.56 $14,033.25
Disclosure

SEC source: 0001303609-26-000002 · primary_doc.xml · nonDerivative · entry 1

Jaumot Frank E · CIK 0001303609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150

Read SEC document
March 19, 2026 Filed Mar 23, 2026 17:21 UTC
Hosseinion WarrenDirector · President
PurchaseCommon Stock 252 $94.07 $23,706.22
Disclosure

SEC source: 0001438327-26-000002 · primary_doc.xml · nonDerivative · entry 1

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,765

Read SEC document
March 17, 2026 Filed Mar 18, 2026 14:40 UTC PurchaseCommon Stock 10 $94.46 $944.60
Disclosure

SEC source: 0002018803-26-000002 · primary_doc.xml · nonDerivative · entry 1

Spears Kelvin · CIK 0002018803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,137

Read SEC document
March 13, 2026 Filed Mar 16, 2026 19:02 UTC
Montgomery Pamela W.Chief Legal Officer-Healthcare
PurchaseCommon Stock 79 $88.87 $7,020.72
Disclosure

SEC source: 0001919434-26-000002 · primary_doc.xml · nonDerivative · entry 1

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,758

Read SEC document
March 11, 2026 Filed Mar 11, 2026 16:35 UTC
Bates Jon ChristianChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 1,694 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001938758-26-000001 · primary_doc.xml · derivative · entry 2

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,527

Underlying: Common Stock · 1,694 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On March 11, 2026, the Reporting Person was granted 1,694 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

F2 · derivative.expiration_date: On March 11, 2026, the Reporting Person was granted 1,694 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Read SEC document
March 11, 2026 Filed Mar 24, 2026 19:41 UTC
Bamburg Wesley ShaneChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 2,411 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0002093295-26-000001 · primary_doc.xml · derivative · entry 1

Bamburg Wesley Shane · CIK 0002093295 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,411

Underlying: Common Stock · 2,411 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F1 · shares: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: On March 11, 2026, the Reporting Person was granted 2,411 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

F2 · derivative.expiration_date: On March 11, 2026, the Reporting Person was granted 2,411 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 16:35 UTC
Bates Jon ChristianChief Financial Officer
Exercise / conversionCommon Stock 2,667 $0.00 $0.00
Disclosure

SEC source: 0001938758-26-000001 · primary_doc.xml · nonDerivative · entry 1

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,305

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 18:27 UTC
Luqman Elisa VChief Legal Officer - SEC
Exercise / conversionRestricted Stock Units · Derivative 1,525 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001486189-26-000003 · primary_doc.xml · derivative · entry 3

Luqman Elisa V · CIK 0001486189 · Chief Legal Officer - SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,441

Underlying: Common Stock · 1,525 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

F3 · derivative.expiration_date: On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 18:27 UTC
Luqman Elisa VChief Legal Officer - SEC
Tax withholdingCommon Stock 784 $86.22 $67,598.36
Disclosure

SEC source: 0001486189-26-000003 · primary_doc.xml · nonDerivative · entry 2

Luqman Elisa V · CIK 0001486189 · Chief Legal Officer - SEC

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (4)

Disclosed balance after: 2,370

F2 · shares: Of the 2,084 shares issued subsequent to vesting, 784 shares were sold to cover tax withholding obligations.

F4 · ownership.nature: The Reporting Person directly owns 2,360 shares. Additionally, the Reporting Person indirectly owns 10 shares through their spouse, resulting in a total beneficial ownership of 2,370 shares.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 18:27 UTC
Luqman Elisa VChief Legal Officer - SEC
Exercise / conversionCommon Stock 2,084 $0.00 $0.00
Disclosure

SEC source: 0001486189-26-000003 · primary_doc.xml · nonDerivative · entry 1

Luqman Elisa V · CIK 0001486189 · Chief Legal Officer - SEC

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (4)

Disclosed balance after: 3,154

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · ownership.nature: The Reporting Person directly owns 2,360 shares. Additionally, the Reporting Person indirectly owns 10 shares through their spouse, resulting in a total beneficial ownership of 2,370 shares.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 22:08 UTC
Montgomery Pamela W.Chief Legal Officer-Healthcare
Exercise / conversionRestricted Stock Units · Derivative 1,525 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001919434-26-000001 · primary_doc.xml · derivative · entry 3

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,217

Underlying: Common Stock · 1,525 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units that convert into common stock on a one-for-one basis upon vesting.

F1 · shares: Restricted stock units that convert into common stock on a one-for-one basis upon vesting.

F3 · derivative.exercise_date: On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

F3 · derivative.expiration_date: On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 22:08 UTC
Montgomery Pamela W.Chief Legal Officer-Healthcare
Tax withholdingCommon Stock 776 $86.22 $66,908.58
Disclosure

SEC source: 0001919434-26-000001 · primary_doc.xml · nonDerivative · entry 2

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,679

F2 · shares: Of the 2,084 shares issued subsequent to vesting, 776 shares were sold to cover tax withholding obligations.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 22:08 UTC
Montgomery Pamela W.Chief Legal Officer-Healthcare
Exercise / conversionCommon Stock 2,084 $0.00 $0.00
Disclosure

SEC source: 0001919434-26-000001 · primary_doc.xml · nonDerivative · entry 1

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,455

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units that convert into common stock on a one-for-one basis upon vesting.

F1 · price: Restricted stock units that convert into common stock on a one-for-one basis upon vesting.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 21:52 UTC Exercise / conversionRestricted Stock Units · Derivative 116 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0002018803-26-000001 · primary_doc.xml · derivative · entry 3

Spears Kelvin · CIK 0002018803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 421

Underlying: Common Stock · 116 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 11, 2026, the Reporting Person was granted 116 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

F3 · derivative.expiration_date: On March 11, 2026, the Reporting Person was granted 116 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 21:52 UTC Tax withholdingCommon Stock 82 $86.22 $7,070.24
Disclosure

SEC source: 0002018803-26-000001 · primary_doc.xml · nonDerivative · entry 2

Spears Kelvin · CIK 0002018803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,127

F2 · shares: Of the 183 shares issued subsequent to vesting, 82 shares were sold to cover tax withholding obligations.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 21:52 UTC Exercise / conversionCommon Stock 183 $0.00 $0.00
Disclosure

SEC source: 0002018803-26-000001 · primary_doc.xml · nonDerivative · entry 1

Spears Kelvin · CIK 0002018803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,209

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 21:36 UTC
Chang Michael L.Chief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 1,936 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001919832-26-000001 · primary_doc.xml · derivative · entry 3

Chang Michael L. · CIK 0001919832 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,621

Underlying: Common Stock · 1,936 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: On March 10, 2026, the Reporting Person was granted 1,936 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

F4 · derivative.expiration_date: On March 10, 2026, the Reporting Person was granted 1,936 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 21:36 UTC
Chang Michael L.Chief Medical Officer
Tax withholdingCommon Stock 769 $86.22 $66,305.03
Disclosure

SEC source: 0001919832-26-000001 · primary_doc.xml · nonDerivative · entry 2

Chang Michael L. · CIK 0001919832 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (3)

Disclosed balance after: 82,356

F2 · shares: Of the 2,084 shares issued subsequent to vesting, 769 shares were sold to cover tax withholding obligations.

F3 · ownership.nature: Michael Chang PLLC ("CHANG") is the direct beneficial owner of 82,356 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 21:36 UTC
Chang Michael L.Chief Medical Officer
Exercise / conversionCommon Stock 2,084 $0.00 $0.00
Disclosure

SEC source: 0001919832-26-000001 · primary_doc.xml · nonDerivative · entry 1

Chang Michael L. · CIK 0001919832 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (3)

Disclosed balance after: 83,125

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · ownership.nature: Michael Chang PLLC ("CHANG") is the direct beneficial owner of 82,356 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 21:20 UTC
Hosseinion WarrenDirector · President
Exercise / conversionRestricted Stock Units · Derivative 3,656 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001438327-26-000001 · primary_doc.xml · derivative · entry 3

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,739

Underlying: Common Stock · 3,656 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 11, 2026, the Reporting Person was granted 3,656 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

F3 · derivative.expiration_date: On March 11, 2026, the Reporting Person was granted 3,656 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

F3 · derivative.underlying_shares: On March 11, 2026, the Reporting Person was granted 3,656 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 21:20 UTC
Hosseinion WarrenDirector · President
Tax withholdingCommon Stock 3,274 $86.22 $282,292.14
Disclosure

SEC source: 0001438327-26-000001 · primary_doc.xml · nonDerivative · entry 2

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,513

F2 · shares: Of the 6,293 shares issued subsequent to vesting, 3,274 shares were sold to cover tax withholding obligations.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 21:20 UTC
Hosseinion WarrenDirector · President
Exercise / conversionCommon Stock 6,293 $0.00 $0.00
Disclosure

SEC source: 0001438327-26-000001 · primary_doc.xml · nonDerivative · entry 1

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,787

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 21:01 UTC
Vo Thomas T.Director · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 4,841 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001919945-26-000001 · primary_doc.xml · derivative · entry 3

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,524

Underlying: Common Stock · 4,841 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 11, 2026, the Reporting Person was granted 4,841 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

F3 · derivative.expiration_date: On March 11, 2026, the Reporting Person was granted 4,841 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 21:01 UTC
Vo Thomas T.Director · Chief Executive Officer
Tax withholdingCommon Stock 3,017 $86.22 $260,132.98
Disclosure

SEC source: 0001919945-26-000001 · primary_doc.xml · nonDerivative · entry 2

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (4)

Disclosed balance after: 1,843,196

F2 · shares: Of the 8,334 shares issued subsequent to vesting, 3,017 shares were sold to cover tax withholding obligations.

F4 · ownership.nature: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 1,840,898 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 23,914 of the securities of the registrant reported herein.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 21:01 UTC
Vo Thomas T.Director · Chief Executive Officer
Exercise / conversionCommon Stock 8,334 $0.00 $0.00
Disclosure

SEC source: 0001919945-26-000001 · primary_doc.xml · nonDerivative · entry 1

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (4)

Disclosed balance after: 1,846,213

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · ownership.nature: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 1,840,898 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 23,914 of the securities of the registrant reported herein.

Read SEC document
March 10, 2026 Filed Mar 16, 2026 19:02 UTC
Montgomery Pamela W.Chief Legal Officer-Healthcare
Exercise / conversionRestricted Stock Unit · Derivative 1,523 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001919434-26-000002 · primary_doc.xml · derivative · entry 2

Montgomery Pamela W. · CIK 0001919434 · Chief Legal Officer-Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,441

Underlying: Common Stock · 1.523 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 10, 2026 relating to a transaction dated March 10, 2026.

F1 · derivative.underlying_shares: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 10, 2026 relating to a transaction dated March 10, 2026.

Read SEC document
March 10, 2026 Filed Mar 18, 2026 14:40 UTC Exercise / conversionRestricted Stock Unit · Derivative 116 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0002018803-26-000002 · primary_doc.xml · derivative · entry 2

Spears Kelvin · CIK 0002018803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 339

Underlying: Common Stock · 116 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026.

F1 · balance_after: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026.

Read SEC document
March 10, 2026 Filed Mar 23, 2026 17:21 UTC
Hosseinion WarrenDirector · President
Exercise / conversionRestricted Stock Units · Derivative 3,656 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001438327-26-000002 · primary_doc.xml · derivative · entry 2

Hosseinion Warren · CIK 0001438327 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,465

Underlying: Common Stock · 3,656 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026.

F1 · balance_after: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026.

Read SEC document
March 10, 2026 Filed Apr 10, 2026 20:18 UTC
Vo Thomas T.Director · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 4,841 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001919945-26-000002 · primary_doc.xml · derivative · entry 2

Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,507

Underlying: Common Stock · 4,841 shares

Expires 2029-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · balance_after: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026.

Read SEC document
November 25, 2025 Filed Nov 28, 2025 14:11 UTC
Bates Jon ChristianChief Financial Officer
PurchaseCommon Stock 750 $136.71 $102,532.43
Disclosure

SEC source: 0001938758-25-000005 · primary_doc.xml · nonDerivative · entry 1

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,638

Read SEC document
July 14, 2025 Filed Feb 9, 2026 18:01 UTC GrantRestricted Stock Units (RSUs) · Derivative 603 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001922252-26-000001 · primary_doc.xml · derivative · entry 1

Reed Michael Lee · CIK 0001922252 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 603

Underlying: Common Stock · 603 shares

Expires 2026-07-14

F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F1 · shares: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

F2 · derivative.expiration_date: On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Read SEC document
July 14, 2025 Filed Feb 9, 2026 17:56 UTC GrantRestricted Stock Units (RSUs) · Derivative 603 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001920511-26-000001 · primary_doc.xml · derivative · entry 1

Grenas Cheryl Yvonne · CIK 0001920511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 603

Underlying: Common Stock · 603 shares

Expires 2026-07-14

F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F1 · shares: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

F2 · derivative.expiration_date: On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Read SEC document
July 14, 2025 Filed Feb 9, 2026 18:04 UTC GrantRestricted Stock Units (RSUs) · Derivative 603 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0002018971-26-000001 · primary_doc.xml · derivative · entry 1

Saunders Scott J · CIK 0002018971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 603

Underlying: Common Stock · 603 shares

Expires 2026-07-14

F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F1 · shares: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

F2 · derivative.expiration_date: On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Read SEC document
July 14, 2025 Filed Feb 9, 2026 17:51 UTC GrantRestricted Stock Units (RSUs) · Derivative 603 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001303609-26-000001 · primary_doc.xml · derivative · entry 1

Jaumot Frank E · CIK 0001303609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 603

Underlying: Common Stock · 603 shares

Expires 2026-07-14

F1 · derivative.exercise_price: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F1 · shares: Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

F2 · derivative.exercise_date: On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

F2 · derivative.expiration_date: On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Read SEC document
April 08, 2025 Filed Apr 14, 2025 16:30 UTC
Bates Jon ChristianChief Financial Officer
PurchaseCommon Stock 1,000 $81.81 $81,810.00
Disclosure

SEC source: 0001486189-25-000017 · primary_doc.xml · nonDerivative · entry 3

Bates Jon Christian · CIK 0001938758 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,888

Read SEC document
April 04, 2025 Filed Apr 14, 2025 16:01 UTC
DeTillio JoshuaChief Operating Officer
Tax withholdingCommon Stock 452 $72.10 $32,587.93
Disclosure

SEC source: 0001486189-25-000015 · primary_doc.xml · nonDerivative · entry 2

DeTillio Joshua · CIK 0001997130 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,481

F2 · shares: Of the 2,125 shares issued subsequent to vesting, 452 shares were sold to cover tax withholding obligations.

Read SEC document
April 04, 2025 Filed Apr 14, 2025 13:42 UTC
Luqman Elisa VChief Legal Officer - SEC
Tax withholdingCommon Stock 266 $72.10 $19,177.86
Disclosure

SEC source: 0001486189-25-000010 · primary_doc.xml · nonDerivative · entry 2

Luqman Elisa V · CIK 0001486189 · Chief Legal Officer - SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,070

F2 · shares: Of the 1,250 shares issued subsequent to vesting, 266 shares were sold to cover tax withholding obligations.

F3 · ownership.direct: The Reporting Person directly owns 1,060 shares. Additionally, the Reporting Person indirectly owns 10 shares through their spouse, resulting in a total beneficial ownership of 1,070 shares.

Read SEC document
April 04, 2025 Filed Apr 14, 2025 20:15 UTC Tax withholdingCommon Stock 34 $72.10 $2,451.30
Disclosure

SEC source: 0001486189-25-000016 · primary_doc.xml · nonDerivative · entry 2

Spears Kelvin · CIK 0002018803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,992

F2 · shares: Of the 143 shares issued subsequent to vesting, 34 shares were sold to cover tax withholding obligations.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.